Related Experiment Videos
Genetics of lipoprotein disorders
1Rockefeller University Laboratory of Biochemical Genetics and Metabolism, New York, NY 10021-6399.
Circulation
|April 1, 1993
Summary
Lipoprotein abnormalities, including high LDL cholesterol and low HDL cholesterol, are linked to coronary artery disease. Genetic factors contribute to these abnormal lipoprotein phenotypes, increasing heart disease risk.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Genetics
Background:
- Lipoproteins are essential for lipid transport and metabolism, regulated by specific proteins and receptors.
- Lipoprotein abnormalities are strongly associated with increased susceptibility to coronary artery disease (CAD).
Purpose of the Study:
- To discuss the association between lipoprotein abnormalities and coronary artery disease.
- To highlight the genetic contribution to abnormal lipoprotein phenotypes.
Main Methods:
- Review of existing studies on lipoprotein metabolism and CAD.
- Identification of common lipoprotein abnormalities.
- Discussion of genetic factors influencing lipoprotein phenotypes.
Main Results:
- Four common lipoprotein abnormalities are linked to CAD: elevated LDL cholesterol, reduced HDL cholesterol with increased triglycerides/VLDL, increased remnant/intermediate density lipoproteins, and elevated lipoprotein (a).
- These abnormalities are present in a significant majority (50-80%) of myocardial infarction survivors.
Conclusions:
- Lipoprotein abnormalities are prevalent in individuals with coronary artery disease.
- Understanding the genetic basis of these abnormal lipoprotein phenotypes is crucial for CAD research.